On The Fly
| ShowHide Related Items >><< - 02/15/23
- Veracyte: Value of test for men with high risk prostate cancer validated
- 02/01/23
- Veracyte to present multiple Decipher urologic testing abstracts at ASCO
- 02/01/23
- Veracyte: Data show Afirma testing may help patients with thyroid nodules care
- 01/23/23
- Exagen elects Nova as Executive Chair of board of directors
- $154.55 /
-0.215 (-0.14%) - 12/01/22
- Marriott Vacations raises quarterly dividend by 16% to 72c per share
- 02/09/23
- Unity rises 12.9%
- 02/09/23
- Unity rises 11.5%
- 01/12/23
- Unity falls -8.2%
- 11/02/22
- Cathie Wood's ARK Investment bought 156K shares of Unity today
- 02/22/23
- Tandem Diabetes names Rebecca Robertson as new board chair
- 12/13/22
- Tandem Diabetes to acquire AMF Medical
- 11/10/22
- Tandem Diabetes t:slim X2 care study demonstrates improvement in all endpoints
- 09/08/22
- Tandem Diabetes CFO says 'goal is always to beat' guidance
- 02/22/23
- TransMedics jumps 14% to $73.72 after Q4 results, above-consensus guidance
- 01/25/23
- TransMedics CEO Hassanein sells $801K in company shares
- 02/22/23
- Teladoc falls 7% to $27.23 after Q4 results, below-consensus Q1 guidance
- 01/30/23
- Cathie Wood's ARK Investment bought 373.5K shares of Teladoc today
- 01/26/23
- Cathie Wood's ARK Investment bought 125.7K shares of Teladoc today
- 01/24/23
- Cathie Wood's ARK Investment bought 87.4K shares of Teladoc today
- 02/22/23
- Sleep Number says experiencing early signs of improvement in business in 2023
- 01/27/23
- Sleep Number CFO David Callen to step down, Chris Krusmark named interim CFO
- 10/26/22
- Sleep Number sees improved chip supply in 2023
- 10/26/22
- Sleep Number sees Q4 demand down mid-teens year-over-year
- 01/03/23
- Root says former employee transferred payments without disclosure
- 01/24/23
- Providence acquires billboards lease at 2TS &1600 Broadway, terms undisclosed
- 09/19/22
- Outfront Media to replace Fossil in S&P 600 at open on 9/19
- 02/22/23
- Nvidia sees FY23 capital expenditures $1.1B-$1.3B
- 02/22/23
- Nvidia up 7% to $222.35 after Q4 report
- 02/22/23
- Nvidia announces AI cloud service offerings
- 02/21/23
- Microsoft says Nvidia offering 'full support' for Activision deal
- 01/31/23
- NetApp to reduce worldwide headcount by approximately 8%
- 11/30/22
- NetApp trading resumes
- 11/30/22
- NetApp trading halted, volatility trading pause
- 11/29/22
- NetApp falls 11% to $64.00 after Q2 results and FY23 guidance cut
- 02/07/23
- Becklar partners with Sunnova Energy to launch workforce safety soluton
- 01/25/23
- Sunnova Energy falls -8.5%
- 01/17/23
- Sunnova Energy teams with USAA to bring clean energy services to members
- 12/13/22
- Sunnova Energy rises 13.8%
- 02/22/23
- Mosaic provides 2023 capital allocation strategy
- 02/14/23
- Appaloosa takes stake in Disney, exits position in Mosaic
- 01/24/23
- Mosaic trading resumes
- 01/24/23
- Mosaic trading halted, volatility trading pause
- 02/22/23
- Lucid Group down 8% afterhours at $9.14 after Q4 results and 2023 outlook
- 02/22/23
- Lucid Group: 2023 production guidance of 10,000 -14,000 vehicles
- 02/09/23
- Lucid Group announces $7,500 EV credit on purchase of select Lucid Air models
- 01/27/23
- Lucid Group trading resumes
- 02/14/23
- Cathie Wood's ARK Investment bought 14.8K shares of Joby Aviation today
- 02/14/23
- Joby Aviation announces start of eVTOL aircraft final assembly
- 02/09/23
- Joby completes 2nd stage requirement for FAA commercial certification of eVTOL
- 12/14/22
- Joby Aviation completes second of four System Reviews required by FAA
- 02/21/23
- Imax reports $24M four-day global box office for Disney's "Ant-Man" film
- 02/16/23
- Imax reports record-breaking $61.3M Chinese New Year box office
- 02/14/23
- Imax expands partnership in Indonesia for ten new theaters
- 02/03/23
- FG Group's subsidiary to supply screens to IMAX
- 10/06/22
- Icon selected by BARDA to execute an anthrax vaccine clinical trial
- 01/17/23
- Five9 opens new European R&D hub in Porto, Portugal
- 10/10/22
- Five9 CEO Rowan Trollope resigns, Mike Burkland succeeds
- 01/23/23
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
- 01/12/23
- Evolent Health jumps after announcing expansion of Humana pact
- 11/18/22
- Evolent Health rises 13.8%
- 11/17/22
- Centene signs agreement to sell Magellan Specialty Health to Evolent Health
- 02/20/23
- Etsy tells The Fly 'counterfeit items, fraud explicitly prohibited'
- 02/02/23
- Etsy appoints Colin Stretch as Chief Legal Officer and Corporate Secretary
- 01/10/23
- Amazon expands Buy with Prime service, introduces Reviews from Amazon
- 11/09/22
- Etsy director sells $1.72M in common stock
- 02/22/23
- eBay raises quarterly dividend 14% to 25c per share
- 02/14/23
- eBay Motors announces launch of eBay Guaranteed Fit
- 02/13/23
- eBay acquires 3PM Shield, terms not disclosed
- 02/07/23
- eBay announces 4% workforce reduction
- 11/01/22
- Cheesecake Factory down 8% at $31.31 after Q3 earnings miss
- 11/01/22
- Cheesecake Factory board authorizes increase of 5M shares to buyback program
- 11/01/22
- Cheesecake Factory expects to open up to 13 new restaurants in FY22
- 02/02/23
- Dutch Bros CEO sells $6.0M in common stock
- 01/09/23
- Dutch Bros rises 9.3%
- 11/09/22
- Dutch Bros CEO: No good news on inflation
- 09/20/22
- Dutch Bros appoints Victoria Tullett as chief legal officer
- 12/13/22
- Match Group up 8% after Bloomberg report on Apple App store plans
- 11/13/22
- Fly Intel: Top five weekend stock stories
- 11/10/22
- Google expands its user choice billing pilot
- 11/09/22
- Bumble down 18% after reporting Q3 earnings, giving Q4 guidance
- 02/22/23
- Altice USA reports Q4 broadband organic net additions down 7.7K
- 02/22/23
- Altice USA names Marc Sirota as new CFO
- 02/21/23
- Adeia renews IP license agreement with Altice USA
- 12/01/22
- Altice USA concludes review of Suddenlink business, will continue to operate
- 12/16/22 TD Cowen
- TransMedics price target raised to $70 from $60 at Cowen
- 11/04/22 Canaccord
- TransMedics price target raised to $63 from $58 at Canaccord
- 08/02/22 TD Cowen
- TransMedics price target raised to $50 from $45 at Cowen
- 08/02/22 Oppenheimer
- TransMedics price target raised to $45 from $40 at Oppenheimer
- 01/30/23 TD Cowen
- Evolent Health price target raised to $59 from $57 at Cowen
- 01/06/23 Piper Sandler
- Evolent Health price target raised to $51 from $44 at Piper Sandler
- 12/05/22 Piper Sandler
- Evolent Health price target raised to $44 from $33 at Piper Sandler
- 11/18/22 TD Cowen
- Evolent Health price target raised to $57 from $52 at Cowen
- 01/18/23 Raymond James
- Veracyte downgraded to Market Perform from Outperform at Raymond James
- 01/18/23 Raymond James
- Veracyte downgraded to Market Perform from Outperform at Raymond James
- 01/05/23 Scotiabank
- Veracyte initiated with Outperform, $33 target at Scotiabank
- 01/04/23 Scotiabank
- Veracyte initiated with an Outperform at Scotiabank
- 02/22/23 Piper Sandler
- Nvidia price target raised to $225 from $200 at Piper Sandler
- 02/21/23 BMO Capital
- Nvidia price target raised to $240 from $210 at BMO Capital
- 02/21/23 Stifel
- Nvidia price target raised to $207 from $175 at Stifel
- 02/21/23 Morgan Stanley
- Nvidia price target raised to $246 from $175 at Morgan Stanley
- 11/16/22 Deutsche Bank
- Joby Aviation price target lowered to $6 from $7 at Deutsche Bank
- 11/15/22 Barclays
- Joby Aviation price target lowered to $4.50 from $6 at Barclays
- 08/16/22 Deutsche Bank
- Joby Aviation price target lowered to $7 from $8 at Deutsche Bank
- 07/27/22 Raymond James
- Joby Aviation initiated with a Market Perform at Raymond James
- 02/02/23 Deutsche Bank
- Etsy price target raised to $115 from $95 at Deutsche Bank
- 01/27/23 Oppenheimer
- Etsy price target raised to $150 from $125 at Oppenheimer
- 01/25/23 JMP Securities
- Etsy price target raised to $140 from $120 at JMP Securities
- 01/05/23 Wolfe Research
- Etsy initiated with a Peer Perform at Wolfe Research
- 02/16/23 Piper Sandler
- ACV Auctions downgraded to Neutral on valuation at Piper Sandler
- 02/16/23 Piper Sandler
- ACV Auctions downgraded to Neutral from Overweight at Piper Sandler
- 01/05/23 Needham
- ACV Auctions named Top Pick for 2023, added to Conviction List at Needham
- 11/10/22 Citi
- ACV Auctions price target lowered to $11 from $13 at Citi
- 01/17/23 JMP Securities
- Root price target lowered to $20 from $25 at JMP Securities
- 12/14/22 Citi
- Citi expands P&C insurance coverage with Arthur J. Gallagher top pick
- 12/14/22 Citi
- Root initiated with a Neutral at Citi
- 11/17/22 Keefe Bruyette
- Root initiated with a Market Perform at Keefe Bruyette
- 12/19/22 Lake Street
- Spok assumed with a Buy at Lake Street
- 10/28/22 Lake Street
- Spok price target raised to $15 at Lake Street after Q3 earnings
- 09/23/22 Lake Street
- Spok initiated with a Buy at Lake Street
- 02/14/23 Evercore ISI
- Sunnova Energy price target lowered to $31 from $35 at Evercore ISI
- 01/25/23 Barclays
- Sunnova Energy price target lowered to $31 from $35 at Barclays
- 01/06/23 Wells Fargo
- Sunnova Energy upgraded to Overweight from Equal Weight at Wells Fargo
- 12/22/22 Piper Sandler
- Sunnova Energy price target raised to $26 from $25 at Piper Sandler
- 02/07/23 Piper Sandler
- Bumble price target raised to $27 from $20 at Piper Sandler
- 01/30/23 Deutsche Bank
- Bumble price target raised to $27 from $22 at Deutsche Bank
- 01/24/23 Jefferies
- Match Group, Bumble price targets raised at Jefferies ahead of earnings
- 01/24/23 Loop Capital
- Bumble price target raised to $25 from $17 at Loop Capital
- 12/23/22 Truist
- Teladoc trends not different despite stock fall, says Truist
- 12/13/22 Citi
- Teladoc price target lowered to $33 from $36 at Citi
- 10/27/22 Oppenheimer
- Teladoc price target lowered to $45 from $55 at Oppenheimer
- 10/27/22 Canaccord
- Teladoc price target lowered to $43 from $45 at Canaccord
- 01/25/23 Morgan Stanley
- Lucid Group price target lowered to $5 from $10 at Morgan Stanley
- 01/22/23 Citi
- Lucid Group resumed with a Buy at Citi
- 01/12/23 Cantor Fitzgerald
- Lucid's Q4 production pre-announcement 'encouraging, says Cantor Fitzgerald
- 01/12/23 Evercore ISI
- Evercore ISI says Lucid FY/Q4 production serves as glimmer of execution progress
- 02/09/23 Morgan Stanley
- AppLovin signs of stability 'count as a win,' says Morgan Stanley
- 01/25/23 Barclays
- Unity price target raised to $33 from $22 at Barclays
- 01/12/23 Jefferies
- Unity downgraded to Underperform from Hold at Jefferies
- 12/08/22 BTIG
- Unity downgraded to Neutral from Buy at BTIG
- 02/16/23 Guggenheim
- Guggenheim starts Dutch Bros at Neutral following 45% year-to-date rally
- 02/16/23 Guggenheim
- Dutch Bros initiated with a Neutral at Guggenheim
- 01/26/23 Barclays
- Dutch Bros price target raised to $31 from $29 at Barclays
- 01/24/23 Wedbush
- Dutch Bros initiated with a Neutral at Wedbush
- 02/22/23 Oppenheimer
- DexCom selloff on Apple article should be bought, says Oppenheimer
- 01/26/23 Wolfe Research
- Tandem Diabetes initiated with a Peer Perform at Wolfe Research
- 12/13/22 Piper Sandler
- Piper 'cautious' on Tandem Diabetes acquisition but stays Overweight
- 12/12/22 Citi
- Tandem Diabetes price target raised to $55 from $50 at Citi
- 01/23/23 MKM Partners
- Five9 price target raised to $95 from $70 at MKM Partners
- 01/18/23 KeyBanc
- Five9 price target raised to $86 from $61 at KeyBanc
- 01/06/23 Needham
- Five9 price target raised to $90 from $75 at Needham, named 2023 Top Pick
- 01/05/23 Jefferies
- Verint downgraded to Hold from Buy at Jefferies
- 02/09/23 Macquarie
- Macquarie raises price target on top theatre pick for 2023
- 01/03/23 Barrington
- Barrington reveals 10 best stock ideas for 2023
- 12/05/22 B. Riley
- Imax price target raised to $23 from $20 at B. Riley
- 11/11/22 Wedbush
- Imax added to Best Ideas List at Wedbush
- 02/22/23 TD Cowen
- eBay price target raised to $48 from $45 at Cowen
- 02/21/23 BofA
- eBay price target raised to $52 from $44 at BofA
- 12/13/22 Citi
- eBay initiated with a Neutral at Citi
- 12/05/22
- eBay participates in a conference call with Mizuho
- 02/02/23 Piper Sandler
- Sleep Number price target raised to $35 from $26 at Piper Sandler
- 10/27/22 Wedbush
- Sleep Number price target lowered to $27 from $33 at Wedbush
- 10/27/22 Piper Sandler
- Sleep Number price target lowered to $26 from $36 at Piper Sandler
- 06/14/22 Piper Sandler
- Sleep Number price target lowered to $40 from $49 at Piper Sandler
- 08/12/22 Barrington
- Outfront Media price target lowered to $27 from $33 at Barrington
- 07/07/22 Citi
- Outfront Media price target lowered to $28 from $30 at Citi
- 06/10/22 Morgan Stanley
- Outfront Media price target lowered to $22 from $33 at Morgan Stanley
- 01/23/23 TD Securities
- Altice USA downgraded to Hold at TD Securities amid U.S. broadband challenges
- 01/23/23 TD Securities
- Altice USA downgraded to Hold from Buy at TD Securities
- 01/17/23 Exane BNP Paribas
- Altice USA downgraded to Underperform from Neutral at Exane BNP Paribas
- 01/10/23 Goldman Sachs
- Altice USA downgraded to Neutral from Buy at Goldman Sachs
- 02/09/23 OTR Global
- NetApp downgraded to Mixed from Positive view at OTR Global
- 02/06/23 Credit Suisse
- Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut
- 01/10/23 Barclays
- NetApp downgraded to Equal Weight from Overweight at Barclays
- 12/20/22 JPMorgan
- NetApp downgraded to Neutral from Overweight at JPMorgan
- $154.55 /
-0.215 (-0.14%) - 02/06/23 BofA
- BofA starts Marriott Vacations at Neutral amid questions on sustainability
- 02/06/23 BofA
- Marriott Vacations initiated with a Neutral at BofA
- 02/03/23 Jefferies
- Marriott Vacations price target lowered to $184 from $195 at Jefferies
- 11/15/22 Truist
- Marriott Vacations price target raised to $205 from $202 at Truist
- 01/25/23 UBS
- Cheesecake Factory downgraded to Sell from Neutral at UBS
- 01/24/23 Raymond James
- Cheesecake Factory downgraded to Market Perform from Outperform at Raymond James
- 01/24/23 Raymond James
- Cheesecake Factory downgraded to Market Perform at Raymond James
- 01/17/23 Gordon Haskett
- Cheesecake Factory downgraded to Hold from Accumulate at Gordon Haskett
- 01/20/23 Guggenheim
- Icon price target raised to $262 from $255 at Guggenheim
- 01/17/23 Barclays
- Icon upgraded to Overweight from Equal Weight at Barclays
- 01/13/23 Barclays
- Icon upgraded to Overweight from Equal Weight at Barclays
- 01/12/23 Baird
- Icon price target raised to $265 from $260 at Baird
- 02/21/23 HSBC
- Mosaic downgraded to Reduce from Hold at HSBC
- 01/30/23 RBC Capital
- Mosaic price target lowered to $55 from $60 at RBC Capital
- 01/24/23 UBS
- Mosaic downgraded to Neutral from Buy at UBS
- 01/20/23 Citi
- Mosaic downgraded to Neutral from Buy at Citi
- 02/22/23
- Veracyte sees FY23 revenue $325M-$335M, consensus $329.57M
- 02/22/23
- Veracyte reports Q4 EPS (5c), consensus (15c)
- 11/02/22
- Veracyte raises FY2 revenue view to $288M-$293M from $272M-$280M
- 11/02/22
- Veracyte reports Q3 EPS (12c), consensus (25c)
- $154.55 /
-0.215 (-0.14%) - 02/22/23
- Marriott Vacations sees FY23 adjusted EPS $10.75-$11.54, consensus $11.60
- 02/22/23
- Marriott Vacations reports Q4 adjusted EPS $2.74, consensus $2.72
- 10/31/22
- Marriott Vacations raises FY22 adjusted EPS to $10.20-$10.64, consensus $9.94
- 10/31/22
- Marriott Vacations reports Q3 adjusted EPS $3.02, consensus $2.60
- 02/22/23
- Unity sees FY23 revenue $2.05B-$2.2B, consensus $2.22B
- 02/22/23
- Unity sees Q1 revenue $470M-$480M, consensus $524.79M
- 02/22/23
- Unity Software reports Q4 adjusted operating income $13M
- 02/22/23
- Tandem Diabetes sees FY23 revenue $885M-$900M, consensus $891.6M
- 02/22/23
- Tandem Diabetes reports Q4 EPS (25c), consensus (6c)
- 01/10/23
- Tandem Diabetes sees FY22 revenue at 'approximately' $805M, consensus $802.5M
- 02/22/23
- TransMedics sees 2023 revenue $$138M-$145M, consensus $134.71M
- 02/22/23
- TransMedics reports Q4 EPS (21c), consensus (30c)
- 11/03/22
- TransMedics raises FY22 revenue view to $80M-$85M from $67M-$75M
- 11/03/22
- TransMedics reports Q3 EPS (25c), consensus (41c)
- 02/22/23
- Teladoc sees FY23 EPS ($1.75)-($1.25), consensus ($1.41)
- 02/22/23
- Teladoc sees Q1 EPS (55c)-(45c), consensus (41c)
- 02/22/23
- Teladoc reports Q4 EPS ($23.49), consensus (25c)
- 02/22/23
- Spok sees FY23 revenue $129M-$136.5M
- 02/22/23
- Spok reports Q4 EPS $1.21 vs (86c) last year
- 02/22/23
- Sleep Number sees Q1 revenue flat to up low single digits, consensus $730.91M
- 02/22/23
- Sleep Number sees FY23 EPS $1.25-$2.00, consensus $1.76
- 02/22/23
- Sleep Number reports Q4 EPS (24c), consensus (22c)
- 01/27/23
- Sleep Number reports preliminary FY22 EPS $1.60, consensus $1.71
- 02/22/23
- Root reports Q4 EPS ($4.13), consensus ($4.54)
- 02/22/23
- Outfront Media reports Q4 EPS 34c, consensus 37c
- 11/03/22
- Outfront Media reports Q3 EPS 23c, consensus 25c
- 02/22/23
- Nvidia sees Q1 revenue $6.5B plus of minus 2%, consensus $6.33B
- 02/22/23
- Nvidia reports Q4 EPS 88c, consensus 81c
- 02/22/23
- Notable companies reporting after market close
- 11/16/22
- Nvidia sees Q4 revenue $6B, +/- 2%, consensus $6.09B
- 02/22/23
- NetApp sees FY23 EPS $5.30-$5.50, consensus $5.41
- 02/22/23
- NetApp sees Q4 EPS $1.30-$1.40, consensus $1.43
- 02/22/23
- NetApp reports Q3 EPS $1.37, consensus $1.31
- 02/22/23
- Sunnova Energy sees FY23 adjusted EBITDA $235M-$255M
- 02/22/23
- Sunnova Energy reports Q4 EPS (18c), consensus (37c)
- 10/26/22
- Sunnova backs FY22 adjusted EBITDA view $117M-$137M
- 02/22/23
- Mosaic reports Q4 adjusted EPS $1.74, consensus $2.26
- 11/07/22
- Mosaic reports Q3 EPS $2.42, consensus $3.40
- 11/07/22
- Notable companies reporting after market close
- 02/22/23
- Lucid Group reports Q4 EPS (28c), consensus (40c)
- 11/08/22
- Lucid Group reports Q3 EPS (40c), consensus (31c)
- 11/08/22
- Notable companies reporting after market close
- 02/22/23
- Joby Aviation reports Q4 adjusted EBITDA ($77.6M) vs. ($65.2M) y/y
- 02/22/23
- Imax reports Q4 adjusted EPS 19c, consensus 20c
- 10/31/22
- Imax reports Q3 adjusted EPS (5c), consensus 3c
- 02/22/23
- Icon sees FY23 EPS $12.40-$13.05, consensus $12.56
- 02/22/23
- Icon reports Q4 EPS $3.13, consensus $3.05
- 01/10/23
- Icon sees FY23 adjusted EPS $12.40-$13.05, consensus $12.34
- 11/02/22
- Icon reaffirms FY22 adjusted EPS view $11.65-$11.85, consensus $11.66
- 02/22/23
- Five9 sees FY23 EPS $1.67-$1.71, consensus $1.57
- 02/22/23
- Five9 sees Q1 EPS 23c-25c, consensus 21c
- 02/22/23
- Five9 reports Q4 EPS 54c, consensus 41c
- 11/08/22
- Five9 sees FY23 EPS $1.36-$1.78, consensus $1.78
- 02/22/23
- Evolent Health sees Q1 revenue $420M-$440M, consensus $410.36M
- 02/22/23
- Evolent Health sees FY23 revenue $1.92B-$1.96B, consensus $1.76B
- 02/22/23
- Evolent Health reports Q4 adjusted EPS 10c, consensus 16c
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- 02/22/23
- Etsy Sees Q1 revenue $600M-$640M, consensus $621.61M
- 02/22/23
- Etsy reports Q4 EPS 77c, consensus 80c
- 11/02/22
- Etsy sees Q4 revenue 700M-$780M, consensus $742.04M
- 02/22/23
- eBay sees Q1 adjusted EPS $1.05-$1.09, consensus $1.06
- 02/22/23
- eBay reports Q4 adjusted EPS $1.07, consensus $1.06
- 11/02/22
- eBay raises FY22 adjusted EPS view to $4.07-$4.13 from $3.95-$4.10
- 02/22/23
- Cheesecake Factory sees Q1 revenue $850M-$880M, consensus $862.8M
- 02/22/23
- Cheesecake Factory sees FY23 revenue $3.5B-$3.6B, consensus $3.52B
- 02/22/23
- Cheesecake Factory reports Q4 adjusted EPS 56c, consensus 57c
- 02/22/23
- Dutch Bros sees FY23 revenue $950M-$1B, consensus $980.63M
- 02/22/23
- Dutch Bros reports Q4 adjusted EPS 3c, consensus 7c
- 11/09/22
- Dutch Bros sees 2022 revenue at least $725M, consensus $724.5M
- 11/09/22
- Dutch Bros reports Q3 EPS 9c, consensus 8c
- 02/22/23
- Bumble sees FY23 revenue growth of 16%-19%
- 02/22/23
- Bumble sees Q1 revenue $238M-$243M, consensus $241.7M
- 02/22/23
- Bumble reports Q4 adjusted EBITDA $60.5M vs. $58.4M y/y
- 02/22/23
- Altice USA reports Q4 GAAP EPS (43c) vs. 56c y/y
- 11/02/22
- Altice USA reports Q3 EPS 19c, consensus 35c
- 11/02/22
- Notable companies reporting after market close
- 02/22/23
- ACV Auctions sees FY23 revenue $460M-$470M, consensus $462.39M
- 02/22/23
- ACV Auctions sees Q1 revenue $107M-$110M, consensus $105.95M
- 02/22/23
- ACV Auctions reports Q4 revenue $98M, consensus $99.25M
- 11/09/22
- ACV Auctions sees FY22 revenue $ $421M-$424M, consensus $428M
|